ENO1 promotes antitumor immunity by destabilizing PD-L1 in NSCLC

被引：0
|
作者：
Chunyi Zhang
Kunpeng Zhang
Jie Gu
Di Ge
机构：
[1] Fudan University,Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences
[2] Fudan University,Department of Chest Surgery, Zhongshan Hospital
来源：
Cellular & Molecular Immunology | 2021年 / 18卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2045 / 2047
页数：2
相关论文
共 50 条
  • [1] ENO1 promotes antitumor immunity by destabilizing PD-L1 in NSCLC
    Zhang, Chunyi
    Zhang, Kunpeng
    Gu, Jie
    Ge, Di
    CELLULAR & MOLECULAR IMMUNOLOGY, 2021, 18 (08) : 2045 - 2047
  • [2] Zosuquidar Promotes Antitumor Immunity by Inducing Autophagic Degradation of PD-L1
    Ding, Ling
    Guo, Hongjie
    Zhang, Jie
    Zheng, Mingming
    Zhang, Wenjie
    Wang, Longsheng
    Du, Qianqian
    Zhou, Chen
    Xu, Yanjun
    Wu, Honghai
    He, Qiaojun
    Yang, Bo
    ADVANCED SCIENCE, 2024, 11 (41)
  • [3] L-5-hydroxytryptophan promotes antitumor immunity by inhibiting PD-L1 inducible expression
    Huang, Jing
    Wang, Xiaobo
    Li, Bing
    Shen, Shiyu
    Wang, Ruina
    Tao, Hongru
    Hu, Junchi
    Yu, Jin
    Jiang, Hualiang
    Chen, Kaixian
    Luo, Cheng
    Dang, Yongjun
    Zhang, Yuanyuan
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (06)
  • [4] Function of PD-L1 in antitumor immunity of glioma cells
    Lou Yongli
    Shi Jin
    Guo Dewei
    Qureshi, Ahmad Kaleem
    Song Laijun
    SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2017, 24 (04) : 803 - 807
  • [5] Targeting of exosomal PD-L1 to induce antitumor immunity
    不详
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (08) : 1624 - 1624
  • [6] KEAP1 promotes anti-tumor immunity by inhibiting PD-L1 expression in NSCLC
    Li, Jinghan
    Shi, Daiwang
    Li, Siyi
    Shi, Xiang
    Liu, Yu
    Zhang, Yi
    Wang, Gebang
    Zhang, Chenlei
    Xia, Tian
    Piao, Hai-long
    Liu, Hong-Xu
    CELL DEATH & DISEASE, 2024, 15 (02)
  • [7] Regorafenib Promotes Antitumor Immunity via Inhibiting PD-L1 and IDO1 Expression in Melanoma
    Wu, Rui-Yan
    Kong, Peng-Fei
    Xia, Liang-Ping
    Huang, Yun
    Li, Zhi-Ling
    Tang, Yun-Yun
    Chen, Yu-Hong
    Li, Xuan
    Senthilkumar, Ravichandran
    Zhang, Hai-Liang
    Sun, Ting
    Xu, Xue-Lian
    Yu, Yan
    Mai, Jia
    Peng, Xiao-Dan
    Yang, Dong
    Zhou, Li-Huan
    Feng, Gong-Kan
    Deng, Rong
    Zhu, Xiao-Feng
    CLINICAL CANCER RESEARCH, 2019, 25 (14) : 4530 - 4541
  • [8] Liposome-mediated PD-L1 multivalent binding promotes the lysosomal degradation of PD-L1 for T cell-mediated antitumor immunity
    Yang, Suah
    Shim, Man Kyu
    Song, Sukyung
    Cho, Hanhee
    Choi, Jiwoong
    Jeon, Seong Ik
    Kim, Woo Jun
    Um, Wooram
    Park, Jae Hyung
    Yoon, Hong Yeol
    Kim, Kwangmeyung
    BIOMATERIALS, 2022, 290
  • [9] Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1
    Cha, Jong-Ho
    Yang, Wen-Hao
    Xia, Weiya
    Wei, Yongkun
    Chan, Li-Chuan
    Lim, Seung-Oe
    Li, Chia-Wei
    Kim, Taewan
    Chang, Shih-Shin
    Lee, Heng-Huan
    Hsu, Jennifer L.
    Wang, Hung-Ling
    Kuo, Chu-Wei
    Chang, Wei-Chao
    Hadad, Sirwan
    Purdie, Colin A.
    McCoy, Aaron M.
    Cai, Shirong
    Tu, Yizheng
    Litton, Jennifer K.
    Mittendorf, Elizabeth A.
    Moulder, Stacy L.
    Symmans, William F.
    Thompson, Alastair M.
    Piwnica-Worms, Helen
    Chen, Chung-Hsuan
    Khoo, Kay-Hooi
    Hung, Mien-Chie
    MOLECULAR CELL, 2018, 71 (04) : 606 - +
  • [10] Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity
    Dorand, R. Dixon
    Nthale, Joseph
    Myers, Jay T.
    Barkauskas, Deborah S.
    Avril, Stefanie
    Chirieleison, Steven M.
    Pareek, Tej K.
    Abbott, Derek W.
    Stearns, Duncan S.
    Letterio, John J.
    Huang, Alex Y.
    Petrosiute, Agne
    SCIENCE, 2016, 353 (6297) : 399 - 403
12345